These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18688096)

  • 1. The last tangle of tau.
    Ding H; Johnson GV
    J Alzheimers Dis; 2008 Aug; 14(4):441-7. PubMed ID: 18688096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tau aggregation toxic or protective?
    Congdon EE; Duff KE
    J Alzheimers Dis; 2008 Aug; 14(4):453-7. PubMed ID: 18688098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the toxicity of tau aggregation.
    Rankin CA; Gamblin TC
    J Alzheimers Dis; 2008 Aug; 14(4):411-6. PubMed ID: 18688091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauopathies: recent insights into old diseases.
    Delacourte A
    Folia Neuropathol; 2005; 43(4):244-57. PubMed ID: 16416389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau aggregates and tau pathology.
    Hernández F; Avila J
    J Alzheimers Dis; 2008 Aug; 14(4):449-52. PubMed ID: 18688097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase activation precedes and leads to tangles.
    de Calignon A; Fox LM; Pitstick R; Carlson GA; Bacskai BJ; Spires-Jones TL; Hyman BT
    Nature; 2010 Apr; 464(7292):1201-4. PubMed ID: 20357768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From tau phosphorylation to tau aggregation: what about neuronal death?
    Buée L; Troquier L; Burnouf S; Belarbi K; Van der Jeugd A; Ahmed T; Fernandez-Gomez F; Caillierez R; Grosjean ME; Begard S; Barbot B; Demeyer D; Obriot H; Brion I; Buée-Scherrer V; Maurage CA; Balschun D; D'hooge R; Hamdane M; Blum D; Sergeant N
    Biochem Soc Trans; 2010 Aug; 38(4):967-72. PubMed ID: 20658986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau oligomers and aggregation in Alzheimer's disease.
    Meraz-Ríos MA; Lira-De León KI; Campos-Peña V; De Anda-Hernández MA; Mena-López R
    J Neurochem; 2010 Mar; 112(6):1353-67. PubMed ID: 19943854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models.
    Sarkar S
    J Genet; 2018 Jul; 97(3):783-793. PubMed ID: 30027909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy.
    Takashima A
    J Alzheimers Dis; 2008 Aug; 14(4):371-5. PubMed ID: 18688086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat.
    d'Orange M; Aurégan G; Cheramy D; Gaudin-Guérif M; Lieger S; Guillermier M; Stimmer L; Joséphine C; Hérard AS; Gaillard MC; Petit F; Kiessling MC; Schmitz C; Colin M; Buée L; Panayi F; Diguet E; Brouillet E; Hantraye P; Bemelmans AP; Cambon K
    Brain; 2018 Feb; 141(2):535-549. PubMed ID: 29253129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau aggregates: toxic, inert, or protective species?
    Bretteville A; Planel E
    J Alzheimers Dis; 2008 Aug; 14(4):431-6. PubMed ID: 18688094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated tau: toxic, protective, or none of the above.
    Castellani RJ; Nunomura A; Lee HG; Perry G; Smith MA
    J Alzheimers Dis; 2008 Aug; 14(4):377-83. PubMed ID: 18688087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological tau: a loss of normal function or a gain in toxicity?
    Trojanowski JQ; Lee VM
    Nat Neurosci; 2005 Sep; 8(9):1136-7. PubMed ID: 16127446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.